Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-27T19:25:30.273Z Has data issue: false hasContentIssue false
  • English
  • Français

A linkage study of schizophrenia with DNA markers from the long arm of chromosome 11

Published online by Cambridge University Press:  09 July 2009

M. Gill ,
P. McGuffin ,
E. Parfitt ,
R. Mant ,
P. Asherson ,
D. Collier ,
H. Vallada ,
J. Powell ,
S. Shaikh  and
C. Taylor
...Show all authors
M. Gill*
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
P. McGuffin
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
E. Parfitt
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
R. Mant
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
P. Asherson
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
D. Collier
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
H. Vallada
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
J. Powell
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
S. Shaikh
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
C. Taylor
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
M. Sargeant
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
A. Clements
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
S. Nanko
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
N. Takazawa
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
D. Llewellyn
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
J. Williams
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
S. Whatley
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
R. Murray
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
M. Owen
Affiliation:
Genetics Section, Department of Psychiatry and Department of Neurosciences, Institute of Psychiatry, London; Department of Psychological Medicine, Department of Medical Genetics and Department of Medical Biochemistry, University of Wales College of Medicine, Cardiff; Department of Psychiatry, Teikyo University School of Medicine, Tokyo, Japan
*
1Address for correspondence: Dr M.Gill, Genetics Section, Department of Psychiatry, Institute of Psychiatry, De Crespigny Park. London SE5 8AF.
Get access Rights & Permissions [Opens in a new window]

Synopsis

We report the results of a collaborative linkage study using 12 polymorphic markers (9 loci) from the long arm of chromosome 11, and 24 families multiply affected with schizophrenia and other closely related disorders. This region is of interest because several families have been reported in which balanced translocations involving 11q apparently co-segregate with psychotic illness. In addition, the dopamine D2 receptor, porphobilinogen deaminase, and tyrosinase genes map within the region studied and may be aetiologically involved in schizophrenia. We have primarily analysed genotypic data by the LOD score method using a range of single gene models. In order to minimize error due to mis-specification of genetic parameters we have analysed data from markers at candidate gene loci by the non-parametric extended sib-pair method in addition to the LOD score method. Our results suggest that most of the region can be excluded from containing a gene of major effect in the aetiology of this disease.

Type
Original Articles
Information
Psychological Medicine , Volume 23 , Issue 1 , February 1993 , pp. 27 - 44
Copyright
Copyright © Cambridge University Press 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Aschauer, H., Aschauer-Treiber, G., Isenberg, K., Todd, R., Knesevich, M., Garver, D., Reich, T. & Cloninger, C. (1990). No evidence for linkage between chromosome 5 markers and schizophrenia. Human Heredity 40, 109–115.CrossRefGoogle ScholarPubMed
Baron, M. (1976). Albinism and schizophreniform psychosis: a pedigree study. American Journal of Psychiatry 133, 1070–1073.Google ScholarPubMed
Barton, D., Kwon, B. & Francke, U. (1988). Human tyrosinase gene, mapped to chromosome 11(q14–q21) defines second region of homology with mouse chromosome 7. Genomics 3, 17–24.CrossRefGoogle ScholarPubMed
Bassett, A. S., Jones, B. D., McGillivray, B. C. & Pantzar, J. T. (1988). Partial trisomy chromosome 5 cosegregating with schizophrenia. Lancet i, 799–801.CrossRefGoogle Scholar
Browne, D. L., Gault, J., Thompson, M. B., Hauge, X. Y., Evans, G. A. & Litt, M. (1991). Dinucleotide repeat polymorphism at the D11S527 locus. Nucleic Acids Research 19, 4790.CrossRefGoogle ScholarPubMed
Charmley, P., Nguygen, J., Wei, S. & Gatti, R. A. (1991). Genetic linkage analysis and homology relationships of genes located on human chromosome 11q. Genomics 10, 608–617.CrossRefGoogle ScholarPubMed
Clerget-Darpoux, F. (1991). The uses and abuses of linkage analysis in neuropsychiatric disorder. In The New Genetics of Mental Illness (ed. McGuffin, P. and Murray, R.), pp. 44–57. Butterworth Heinemann: Oxford.CrossRefGoogle Scholar
Clerget-Darpoux, F., Bonaïti-Pellie, C. & Hochez, J. (1986). Effects of misspecifying genetic parameters in lod score analysis. Biometrics 42, 393–399.CrossRefGoogle ScholarPubMed
Crowe, R. R., Black, D. W., Andreasen, N. C. & Huether, M. (1990). The Iowa multiplex family study of schizophrenia: linkage analysis on chromosome 5. European Archives of Psychiatric and Neurological Science 239, 290–292.CrossRefGoogle ScholarPubMed
Detera-Wadleigh, S., Goldin, L., Sherrington, R., Encio, I., de Miguel, C., Berrettini, W., Gurling, H. & Gershon, E. S. (1989). Exclusion of linkage to 5q11–13families with schizophrenia and other psychiatric disorders. Nature 340, 391–393.CrossRefGoogle ScholarPubMed
Giebel, L. B. & Spritz, R. A. (1990). RFLP for Mbol in the human tyrosinase (TYR) gene detected by PCR. Nucleic Acids Research 18, 3103.CrossRefGoogle Scholar
Gottesman, I. I. & Shields, J. (1982). Schizophrenia: The Epigenetic Puzzle. Cambridge University Press: Cambridge.Google Scholar
Grandy, D. K., Litt, M., Allen, L., Bunzow, J. R., Marchionni, M., Makam, H., Reed, L., Magenis, R. E. & Civelli, O. (1989). The human dopamine receptor gene is located on chromosome 11 at q22 q23 and identifies a TaqI RFLP. American Journal of Human Genetics 45, 778–785.Google ScholarPubMed
Hauge, X. Y., Grandy, D., Eubanks, J. H., Evans, G. A., Civelli, O. & Litt, M. (1991). Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. Genomics 10, 527–530.Google Scholar
Holland, A. & Gosden, C. (1990). A balanced chromosomal translocation partially co-segregating with psychotic illness in a family. Psychiatry Research 32, 1–8.CrossRefGoogle ScholarPubMed
James, J. (1971). Frequency in relatives for an all-or-none trait. Annals of Human Genetics 35, 47–59.CrossRefGoogle ScholarPubMed
Julier, C., Nakamura, Y., Lathrop, M., O'Connell, P., Leppert, M., Litt, M., Mohandas, T., Lalouel, J.-M. & White, R. (1990). A detailed genetic map of the long arm of chromosome 11. Genomics 7, 335–345.CrossRefGoogle Scholar
Kaufmann, C., DeLisi, C., Lehner, T. & Gilliam, T. (1989). Physical mapping, linkage analysis of a putative schizophrenia locus on chromosome 5q. Schizophrenia Bulletin 15, 441–452.CrossRefGoogle ScholarPubMed
Kennedy, J. L., Giuffra, L. A., Moises, H. W., Cavalli-Sforza, L. L., Pakstis, A. J., Kidd, J. R., Castiglione, C. M., Sjogren, B., Wetterberg, L. & Kidd, K. K. (1988). Evidence against linkage of schizophrenia to markers on chromosome 5 in a northern Swedish pedigree. Nature 336, 167–169.Google Scholar
Kikuchi, H., Muira, H., Yamamoto, H., Takeuchi, T., Dei, T. & Watamabe, M. (1989). Characteristic sequences in the upstream region of the human tyrosinase gene. Biochimica et Biophysica Acta 1009, 283–286.CrossRefGoogle ScholarPubMed
Lathrop, M., Lalouel, J., Julier, C. & Ott, J. (1984). Strategies for multilocus linkage analysis in humans. Proceedings of the National Academy of Sciences, USA 81, 3443–3446.CrossRefGoogle ScholarPubMed
Leboyer, M. & McGuffin, P. (1991). Collaborative strategies in the molecular genetics of the major psychoses. British Journal of Psychiatry 158, 605–610.CrossRefGoogle ScholarPubMed
Lee, J.-S., Anvret, M., Lindsten, J., Lannfell, L., Gellerfors, P., Wetterberg, L., Floderus, Y. & Thunnell, S. (1988). DNA polymorphisms in the porphobillnogen deaminase gene in two Swedish families with acute intermittent porphyria. Human Genetics 79, 379–381.Google Scholar
Litt, M., Sharma, V. & Luty, J. A. (1990). Dinucleotide repeat polymorphism at the D11S35 locus. Nucleic Acids Research 18, 5921.CrossRefGoogle ScholarPubMed
Llewellyn, D., Kalsheker, N., Elder, G., Harrison, P., Chretian, S. & Goossens, M. (1987). Msp I polymorphism for the human porphobillnogen deaminase gene. Nucleic Acids Research 15, 1349.CrossRefGoogle Scholar
Luo, X. Y., Evans, G. A. & Litt, M. (1991 a). Dinucleotide repeat polymorphism at the D11S420 locus. Nucleic Acids Research 18, 5920.CrossRefGoogle Scholar
Luo, X. Y., Evans, G. A. & Litt, M. (1991 b). Dinucleotide repeat polymorphism at the D11S490 locus. Nucleic Acids Research 18, 7470.CrossRefGoogle Scholar
McConville, C. M., Formstone, C. J., Hernandez, D., Thick, J. & Taylor, A. M. (1990). Fine mapping of the chromosome 11q22–23 region using PFGE, linkage and haplotype analysis; localization of the gene for ataxia telangiectasia to a 5cM region flanked by NCAM/DRD2 and STMY/CJ52. 75,p2.22. Nucleic Acids Research 18, 4335–1343.CrossRefGoogle Scholar
McGue, M. & Gottesman, I. I. (1989). Genetic linkage in schizophrenia: perspectives from genetic epidemiology. Schizophrenia Bulletin 15, 453–464.CrossRefGoogle ScholarPubMed
McGuffin, P. (1988). Genetics of schizophrenia. In Schizophrenia, The Major Issues (ed. Bebbington, P. and McGuffin, P.), pp. 107–126. Heinemann Medical: London.Google Scholar
McGuffin, P. & Sturt, E. (1986). Genetic markers in schizophrenia. Human Heredity 36, 65–68.CrossRefGoogle ScholarPubMed
McGuffin, P., Festenstein, H. & Murray, R. (1983). A family study of HLA and other genetic markers in schizophrenia. Psychological Medicine 13, 31–43.CrossRefGoogle ScholarPubMed
McGuffin, P., Katz, R. & Aldrich, J. (1986). Past and present state examination: the assessment of ‘lifetime ever’ psychopathology. Psychological Medicine 16, 461–465.CrossRefGoogle ScholarPubMed
McGuffin, P., Sargeant, M., Hett, G., Tidmarsh, S., Whatley, S. & Marchbanks, R. M. (1990). Exclusion of a schizophrenia susceptibility gene from the chromosome 5q11–q13 region: new data and a reanalysis of previous reports. American Journal of Human Genetics 47, 524–535.Google Scholar
McGuffin, P., Farmer, A. & Harvey, I. (1992). A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Archives of General Psychiatry, 48, 764–770.CrossRefGoogle Scholar
Moises, H. W., Gelernter, J., Giuffra, L., Zarcone, V., Wetterberg, L., Civelli, O., Kidd, K. K. & Cavalli-Sforza, L. (1991). No linkage between D2 dopamine receptor gene region and schizophrenia. Archives of General Psychiatry 48, 643–647.CrossRefGoogle ScholarPubMed
O'Rourke, D. H., Gottesman, I. I., Suarez, B. K., Rice, J. & Reich, T. (1982). Refutation of the single locus model in the aetiology of schizophrenia. American Journal of Human Genetics 33, 630–649.Google Scholar
Ott, J. (1985). Analysis of Human Genetic Linkage. Johns Hopkins University Press: Baltimore.Google Scholar
Owen, F. & Crow, T. J. (1987). Neurotransmitters and psychosis. British Medical Bulletin 43, 651–671.CrossRefGoogle ScholarPubMed
Owen, M. & McGuffin, P. (1991). DNA and classical genetic markers in schizophrenia. European Archives of Psychiatry and Clinical Neurosciences 240, 169–173.CrossRefGoogle ScholarPubMed
Owen, M., Craufurd, D. & StClair, D. (1990). Localization of a susceptibility locus for schizophrenia on chromosome 5. British Journal of Psychiatry 158, 171–176.Google Scholar
Owen, M., Mant, R., Parfitt, E., Williams, J., Asherson, P., O'Mahoney, G., Van Os, J., Llewellyn, D., Collier, D., Gill, M. & McGuffin, P. (1992). A study of association between RFLPs at the porphobilinogen deaminase gene and schizophrenia. Human Genetics 90, 131–132.CrossRefGoogle ScholarPubMed
Polymeropoulos, M. H., Xiao, H., Rath, D. S. & Merril, C. R. (1990). Dinucleotide repeat polymorphism at the int-2 proto-oncogene locus (INT2). Nucleic Acids Research 18, 7468.Google ScholarPubMed
Risch, N. (1991). A note on multiple testing procedures in linkage analysis. American Journal of Human Genetics 48, 1058–1064.Google ScholarPubMed
Sanders, A., Hamilton, J., Fann, W. & Patel, P. (1991). Association of genetic variation at the porphobilinogen deaminase gene with schizophrenia. American Journal of Human Genetics 49, A2011.Google Scholar
Sandkuijl, L. A. (1989). Analysis of affected sib-pairs using information from extended families. In Multipoint Mapping and Linkage Based upon Affected Pedigree Members. Genetic Analysis Workshop 6 (ed. Elston, R. C., Spence, M. A., Hodge, S. E. and MacCluer, J. W.). Alan R. Liss: New York.Google Scholar
St Clair, D., Blackwood, D., Muir, W., Baillie, D., Hubbard, A., Wright, A. & Evans, H. J. (1989). No linkage of chromosome 5q11–q13 markers to schizophrenia in Scottish families. Nature 339, 305–309.CrossRefGoogle ScholarPubMed
St Clair, D., Blackwood, D., Muir, W., Carothers, A., Walker, M., Spowart, G., Gosden, C. & Evans, H. J. (1990). Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336, 13–16.CrossRefGoogle ScholarPubMed
Sherrington, R., Brynjolffson, J., Pertusson, H., Potter, M., Dudleston, K., Barraclough, B., Wasmuth, J., Dobbs, M. & Gurling, H. (1988). Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 336, 164–167.CrossRefGoogle ScholarPubMed
Smith, C. A. B. (1963). Testing for heterogeneity of recombination values in human genetics. Annals of Human Genetics 27, 175–182.Google Scholar
Smith, M., Wasmuth, J., McPherson, J. D., Wagner, C., Grandy, D., Civelli, O., Potkin, S. & Litt, M. (1989). Cosegregation of an 11q22–9p22 translocation with affective disorder: proximity of the dopamine D2 receptor gene relative to the translocation breakpoint. American Journal of Human Genetics 45, A220.Google Scholar
Southern, E. (1975). Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology 98, 503–517.CrossRefGoogle ScholarPubMed
Spitzer, R. L., Endicott, J. & Robins, E. (1978). Research Diagnostic Criteria for a Selected Group of Functional Disorders, 3rd edn.New York State Psychiatric Institute: New York.Google Scholar
Sturt, E. & McGuffin, P. (1985). Can linkage and marker association resolve the genetic aetiology of psychiatric disorders: review and argument. Psychological Medicine 15, 455–462.CrossRefGoogle ScholarPubMed
Wang, A. L., Arredondo-Vega, F. X., Giampetro, P. F., Smith, M., French Anderson, W. & Desnick, R. J. (1981). Regional gene assignment of human porphobilinogen deaminase and esterase A4 to chromosome 11q 23–11qter. Proceedings of the National Academy of Sciences USA 78, 5734–5738.CrossRefGoogle Scholar
Weber, J. L., Kwitek, A. E. & May, P. E. (1990). Dinucleotide repeat polymorphisms at the D11S419 and CD3D loci. Nucleic Acids Research 18, 4036.CrossRefGoogle ScholarPubMed
Wing, J. K., Cooper, J. E. & Sartorius, N. (1974). The Measurement and Classification of Psychiatric Symptoms. Cambridge University Press: Cambridge.Google Scholar